Adavosertib-Encapsulated Metal-Organic Frameworks for p53-Mutated Gallbladder Cancer Treatment via Synthetic Lethality
Article in Science Bulletin (February 2024)
The most recent citing publications are shown below. View all 64 publications that cite this research output on Dimensions.
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
Article in Cancer Cell International (September 2023)
Inhibitors of cell cycle checkpoint target Wee1 kinase – a patent review (2003–2022)
Article in Expert Opinion on Therapeutic Patents (December 2022)